HMCC Completes Add-On Investment in CareAbout
Amsterdam, 9th of October 2025 – HMCC, a portfolio company of Holland Capital, proudly announces the successful completion of an add-on investment in CareAbout. This step brings together two strong organizations, joining forces to further support healthcare providers in ensuring continuity of care.
Joining forces
For many years, HMCC has been an innovative medical contact center, supporting general practitioners, pharmacies, and clinics remotely. By adding CareAbout to the group, the two companies can take significant steps together to enhance support for GP practices, pharmacies, and clinics across the Netherlands — both on-site and remotely.
Patrick Eliasar, CEO of HMCC, said: “This partnership enables us to serve our clients even better. By joining forces with CareAbout, we not only broaden our range of services, but also strengthen our team and our shared mission to ensure continuity of care.”
Timothy Hoolhorts, CEO of CareAbout, added: “We are very excited to take this step together with HMCC. This partnership allows us to expand our services and support healthcare organizations more comprehensively — from communication services to staffing solutions.”
Sterre Witteveen, Investment Manager at Holland Capital, commented: “We are impressed by the strong performance of both companies and see great added value in their combination. This partnership aligns perfectly with our broad healthcare portfolio, in which we consistently invest in innovative companies that improve the quality and accessibility of care.”
About HMCC
HMCC specializes in delivering remote healthcare services. The company supports pharmacies, GP practices, and clinics with experienced remote medical assistants, pharmacy assistants, and nurses. HMCC’s services ensure optimal accessibility, efficient workflows, and continuity of care.
About CareAbout
CareAbout recruits and places healthcare professionals with GP practices, pharmacies, and other primary care organizations. It offers both flexible and permanent placements, with personal guidance and professional development opportunities for its healthcare providers.
About Holland Capital
Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and fosters an open, sustainable, and professional relationship with the management teams of the invested companies, aiming for mutual growth. With offices in Amsterdam and Düsseldorf, Holland Capital focuses on Healthcare and Technology sector. The company has been actively supporting HMCC in its operational and strategic development since joining as a shareholder in 2023.
Magnus accelerates growth through collaboration with Holland Capital
Magnus accelerates growth through collaboration with Holland Capital Amsterdam / Naarden, November 26, 2020 - Holland Capital invests in consultancy company Magnus, a major player in the field of digital transformation. With its broad IT expertise, Magnus is a...
Holland Capital investeert in innovatieve dienstverlener in logistiek en identificatie AMP Groep
Holland Capital investeert in innovatieve dienstverlener in logistiek en identificatie AMP Groep Amsterdam/Houten, 6 oktober 2020 – Participatiemaatschappij Holland Capital investeert in AMP Groep, een innovatieve dienstverlener in logistiek en identificatie. De...
Holland Capital invests in AMP Groep, an innovative service provider in logistics and identification
Holland Capital invests in AMP Groep, an innovative service provider in logistics and identification Amsterdam / Houten, October 6th, 2020 – Investment firm Holland Capital invests in AMP Groep, an innovative service provider active in the logistics and identification...
U-Needle secures growth financing for the global rollout of its Bella-mu product range
Amsterdam/Enschede, 1st of October 2020 – Holland Capital invests in U-Needle with Waterman Ventures and along with existing shareholders including UT International Ventures incubator fund. U-Needle has developed Bella-mu, a range of needles created for intradermal...
U-Needle trekt groeikapitaal aan voor de wereldwijde uitrol van de Bella-mu
Amsterdam/Enschede, 1 oktober 2020 – Holland Capital investeert samen met Waterman Ventures en bestaande aandeelhouders, waaronder het UT International Ventures incubator fonds, in U-Needle. U-Needle heeft de Bella-mu ontwikkeld, een productlijn van naalden voor de...
Yenlo en Fides bundelen krachten
Amsterdam, 21 september 2020 – Onze deelneming Yenlo (de integratiespecialist op het gebied van API- en ESB-technologie) en Fides (de AFAS migratie- en integratiepartner voor zorg en onderwijs) bundelen hun krachten. Door deze samenwerking kunnen ze de integratie voor...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl